There are three subtypes of PPARs: PPARα, PPARβ/δ, and PPARγ. Currently, the single and dual PPAR agonists have been applied in the clinic for the treatment of hyperlipidemia, T2DM, metabolic syndrome and associated cardiovascular diseases [19]. Here, PPARA is linked to metabolic syndrome.